On Thursday poor air quality continued across parts of the Capital Region as smoke from the Canadian wildfires continues to linger. The skies did look a bit clearer on Thursday than they did Wednesday ...

Ivermectin, which surged in popularity during the coronavirus pandemic amid unproven claims that it could help fight COVID-19 infections, has now found a new following among some cancer patients. "I ...

A landmark study suggests physical activity can help cancer patients live longer. Scientists are learning why. Exercise has long been recommended to help lower the risk of developing cancer. Now, ...

Please provide your email address to receive an email when new articles are posted on . A lifestyle program focused on Mediterranean diet, exercise and vitamin D significantly improved metabolic ...

CHICAGO -- A month-long structured yoga program helped patients with cancer improve mood disturbance, anxiety, and fatigue, contributing to a reduction in insomnia, a large multicenter randomized ...

Randomized data support structured post-adjuvant exercise as a disease-modifying survivorship strategy, improving disease-free survival and overall survival compared with education-only control.

EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer This ...

In 2021, Sarah Siedschlag was diagnosed with breast cancer after finishing a marathon the week before. "I was devastated and scared," she recalled. "I just remember, I wanted to be honest with my kids ...

One of the most entertaining moments in VC this week was a piece of rage-bait marketing from General Catalyst. In a now-viral post on X that parodies the old Mac vs. PC commercials, the venture firm — ...

GILBERT, AZ — A Gilbert business resource center is helping local entrepreneurs not just open their doors but stay in business. It’s called the CATALYST The Gilbert business resource center connects ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The Italian company Angelini Pharma ...